A Kok‐Jensen

A Randomized Clinical Trial of α1-Antitrypsin Augmentation Therapy

Asger Dirksen, Joop H. Dijkman, Flemming Madsen et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 499 citations

Medicine, Clinical Sciences, Internal Medicine +13

Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group

Niels Seersholm, Marion Wencker, Norbert Banik et al. · European Respiratory Journal · 1997 · 308 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Prospective Evaluation of a Whole-Blood Test Using <i>Mycobacterium tuberculosis</i> -Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active Tuberculosis

Pernille Ravn, Martin E. Munk, Åse Bengård Andersen et al. · Clinical and Vaccine Immunology · 2005 · 188 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +9

Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10.

Inger Brock, Martin E. Munk, A Kok‐Jensen et al. · PubMed · 2001 · 179 citations

Public Health, Immunology, Infectious Diseases +15

Persistent High Incidence of Tuberculosis in Immigrants in a Low-Incidence Country

Åse Bengård Andersen, Asger Dirksen, Else Smith et al. · Emerging infectious diseases · 2002 · 169 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17